O

OriGene Technologies

Sells gene-based research tools and reagents

Research Associate - Lentivirus

Full-Time
No salary listed
Mid
Bachelor's
Rockville, MD, USA
In Person
Biology & BiotechTranslational Research & Bench Biology

About the job

Requirements
  • A bachelor's degree in life science and at least 2 years of experience are required.
  • Experience with molecular biology and cell culture skills is required.
  • Ability to multitask under pressure.
  • Ability to plan tasks and manage time effectively to complete projects on time.
  • Ability to understand and comply with ethical, legal, and regulatory requirements applicable to the company.
  • Highly organized and self-motivated.
  • Proficiency in Microsoft software, including word processing, email, spreadsheets, databases, and the Internet.
  • Ability to meet the physical requirements of regularly sitting, walking, talking, hearing, and using hands and fingers, and occasionally standing, reaching, stooping, kneeling, crouching, or crawling.
  • Ability to lift and move up to 25 pounds; requires close, distance, color, and peripheral vision and the ability to adjust focus.
Responsibilities
  • Perform experiments following protocols for cell culture, transfections, virus concentrations, and enzyme-linked immunosorbent assay (ELISA).
  • Keep accurate laboratory records and data.
  • Perform assigned laboratory duties and maintain laboratory stocks, solutions, reagents, and supplies.
  • Collaborate with Operations, Customer Services, and other cross-functional departments to ensure timely delivery of final lentiviral particle products.
Desired Qualifications
  • Previous experience handling lentivirus is highly preferred.
  • Ability to communicate effectively and work as part of a team.

About the company

OriGene Technologies provides gene-based research tools and reagents for academic, pharmaceutical, and biotech researchers. It sells cDNA clones, antibodies, proteins, RNAi, and lentiviral particles directly to research institutions worldwide. It differentiates itself with a very large inventory and a distributed manufacturing network that enables rapid access to a broad set of gene-based tools. Its goal is to help researchers advance gene-based science by providing reliable reagents and educational resources.

Company Size

51-200

Company Stage

Late Stage VC

Total Funding

$69.4M

Headquarters

Rockville, Maryland

Founded

1996

Get referred to OriGene Technologies

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • OriGene launched EV Isolation Reagent and CD9 Exosome ELISA on March 23, 2026.
  • Its August 2026 site highlights broad Simple Western antibody coverage in EV, AAV, oncology.
  • The November 2025 ProteanFect distributorship adds transfection exposure beyond catalog reagents.

What critics are saying

  • August 31, 2026 image-integrity review exposed 2,236 flagged validation images, hurting trust.
  • Nature’s August 25, 2026 report linked OriGene to widespread antibody-image manipulation scrutiny.
  • If validation credibility erodes, academic buyers switch to Abcam, Thermo Fisher, and Bio-Techne.

What makes OriGene Technologies unique

  • OriGene’s September 2026 catalog lists 1,138,382 products across clones, antibodies, proteins.
  • Its June 2025 capability page claims 586K full-length human cDNA clones.
  • KO validation and Simple Western-optimized antibodies anchor its validation-heavy selling proposition.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Mentorship Program
  • Professional Development Budget
  • Conference Attendance Budget
  • Training Programs
  • Professional Certification Support
  • Performance Bonus

Growth & Insights and Company News

6 month growth

1%

1 year growth

0%

2 year growth

3%
OriGene Technologies Inc.
Nov 9th, 2023
CytoSections™ - Use case for antibody validation of the IDH1(R132H) mutation in Glioblastomas

OriGene has developed a tool for antibody validation called CytoSections.